305(top 1%)
PR articles
36.9K(top 0.1%)
PR citations
97(top 0.1%)
PR h-index
104(top 0.1%)
h-index
331
documents
47.3K
doc citations
3.4K
citing journals
100
times ranked

Publications

306 peer-reviewed articles • 40,923 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Journal of Experimental Medicine, 2023, 220,
9.3113Citations (PDF)
2SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Journal of Virology, 2022, 96,
3.680Citations (PDF)
3Host cell-intrinsic innate immune recognition of SARS-CoV-2
Current Opinion in Virology, 2022, 52, 30-38
5.054Citations (PDF)
4Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice
Inflammatory Bowel Diseases, 2022, 28, 318-321
2.97Citations (PDF)
5The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
Cell Host and Microbe, 2022, 30, 53-68.e12
15.172Citations (PDF)
6SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Nature, 2022, 603, 687-692
37.9655Citations (PDF)
7JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis
MBio, 2022, 13,
4.421Citations (PDF)
8Advances and gaps in SARS-CoV-2 infection models
PLoS Pathogens, 2022, 18, e1010161
4.481Citations (PDF)
9Opportunistic experiments to constrain aerosol effective radiative forcing
Atmospheric Chemistry and Physics, 2022, 22, 641-674
4.687Citations (PDF)
10Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
IScience, 2022, 25, 103602
3.56Citations (PDF)
11An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
Nature Medicine, 2022, 28, 490-495
33.0697Citations (PDF)
12Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Science Translational Medicine, 2022, 14,
12.578Citations (PDF)
13A genome-wide CRISPR screen identifies HuR as a regulator of apoptosis induced by dsRNA and virus
Journal of Cell Science, 2022, 135,
2.45Citations (PDF)
14A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
Med, 2022, 3, 188-203.e4
7.021Citations (PDF)
15Innate immunity: the first line of defense against SARS-CoV-2
Nature Immunology, 2022, 23, 165-176
23.5574Citations (PDF)
16Distinct Cellular Tropism and Immune Responses to Alphavirus Infection
Annual Review of Immunology, 2022, 40, 615-649
29.439Citations (PDF)
17Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo
Cell Chemical Biology, 2022, 29, 811-823.e7
6.226Citations (PDF)
18A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
Science Translational Medicine, 2022, 14,
12.5131Citations (PDF)
19Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
Cell, 2022, 185, 1572-1587.e11
33.698Citations (PDF)
20Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Cell Reports, 2022, 38, 110561
6.335Citations (PDF)
21Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
Journal of Experimental Medicine, 2022, 219,
9.325Citations (PDF)
22mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
Med, 2022, 3, 309-324.e6
7.016Citations (PDF)
23Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
MBio, 2022, 13,
4.415Citations (PDF)
24Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Science Translational Medicine, 2022, 14,
12.5114Citations (PDF)
25Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron
Cell Reports, 2022, 39, 110799
6.368Citations (PDF)
26An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
Journal of Clinical Investigation, 2022, 132,
10.636Citations (PDF)
27Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
Nature Biotechnology, 2022, 40, 1336-1340
29.833Citations (PDF)
28Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Nature, 2022, 607, 119-127
37.9246Citations (PDF)
29The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes
MBio, 2022, 13,
4.443Citations (PDF)
30A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice
PLoS Pathogens, 2022, 18, e1010573
4.422Citations (PDF)
31mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
Cell Reports Medicine, 2022, 3, 100653
6.615Citations (PDF)
32IMM-BCP-01, a patient-derived anti–SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2
Science Immunology, 2022, 7,
13.411Citations (PDF)
33A Multitrait Locus Regulates Sarbecovirus Pathogenesis
MBio, 2022, 13,
4.422Citations (PDF)
34Hydrogen–deuterium exchange mass spectrometry identifies spatially distinct antibody epitopes on domain III of the Zika virus envelope protein
Journal of Mass Spectrometry, 2021, 56,
1.710Citations (PDF)
35Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity
Cell Metabolism, 2021, 33, 270-282.e8
25.2357Citations (PDF)
36Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
Nature, 2021, 591, 293-299
37.9744Citations (PDF)
37TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons
Journal of Clinical Investigation, 2021, 131,
10.697Citations (PDF)
38An overview of the ORACLES (ObseRvations of Aerosols above CLouds and their intEractionS) project: aerosol–cloud–radiation interactions in the southeast Atlantic basin
Atmospheric Chemistry and Physics, 2021, 21, 1507-1563
4.6143Citations (PDF)
39Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Nature Medicine, 2021, 27, 717-726
33.0940Citations (PDF)
40Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis
Cell, 2021, 184, 1214-1231.e16
33.667Citations (PDF)
41Itaconate confers tolerance to late NLRP3 inflammasome activation
Cell Reports, 2021, 34, 108756
6.3230Citations (PDF)
42Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
Cell Host and Microbe, 2021, 29, 477-488.e4
15.1794Citations (PDF)
43Murine astrovirus tropism for goblet cells and enterocytes facilitates an IFN-λ response in vivo and in enteroid cultures
Mucosal Immunology, 2021, 14, 751-761
7.046Citations (PDF)
44SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis
JACC Basic To Translational Science, 2021, 6, 331-345
3.3160Citations (PDF)
45Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
Journal of Experimental Medicine, 2021, 218,
9.332Citations (PDF)
46Spatiotemporal Heterogeneity of Aerosol and Cloud Properties Over the Southeast Atlantic: An Observational Analysis
Geophysical Research Letters, 2021, 48,
4.118Citations (PDF)
47The antigenic anatomy of SARS-CoV-2 receptor binding domain
Cell, 2021, 184, 2183-2200.e22
33.6424Citations (PDF)
48The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
Cell Reports, 2021, 35, 108962
6.340Citations (PDF)
49Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Cell, 2021, 184, 2316-2331.e15
33.6404Citations (PDF)
50Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Cell, 2021, 184, 1804-1820.e16
33.6379Citations (PDF)
51A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Cell, 2021, 184, 2229-2238.e13
33.681Citations (PDF)
52Pharmacological activation of STING blocks SARS-CoV-2 infection
Science Immunology, 2021, 6,
13.4187Citations (PDF)
53Hypergraph models of biological networks to identify genes critical to pathogenic viral response
BMC Bioinformatics, 2021, 22,
3.0107Citations (PDF)
54On the road to ending the COVID-19 pandemic: Are we there yet?
Virology, 2021, 557, 70-85
2.343Citations (PDF)
55An Interview with Michael Diamond, MD, PhD
Journal of Interferon and Cytokine Research, 2021, 41, 200-202
1.70Citations (PDF)
56Exploring the elevated water vapor signal associated with the free tropospheric biomass burning plume over the southeast Atlantic Ocean
Atmospheric Chemistry and Physics, 2021, 21, 9643-9668
4.625Citations (PDF)
57Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation
Cell Host and Microbe, 2021, 29, 988-1001.e6
15.1153Citations (PDF)
58SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Nature, 2021, 596, 109-113
37.9819Citations (PDF)
59In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Nature, 2021, 596, 103-108
37.9247Citations (PDF)
60Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets
Immunity, 2021, 54, 1290-1303.e7
22.6143Citations (PDF)
61SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
Immunity, 2021, 54, 1304-1319.e9
22.6161Citations (PDF)
62An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Cell Reports, 2021, 36, 109452
6.3127Citations (PDF)
63Assessment of serological assays for identifying high titer convalescent plasma
Transfusion, 2021, 61, 2658-2667
0.810Citations (PDF)
64Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis
Aging Cell, 2021, 20,
6.817Citations (PDF)
65Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesis
Immunity, 2021, 54, 1417-1432.e7
22.628Citations (PDF)
66Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
Cell Host and Microbe, 2021, 29, 1151-1161.e5
15.172Citations (PDF)
67Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
Cell Reports, 2021, 36, 109364
6.3147Citations (PDF)
68Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
Cell Reports, 2021, 36, 109604
6.3115Citations (PDF)
69Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes
Nature Communications, 2021, 12,
13.731Citations (PDF)
70Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
Cell, 2021, 184, 4414-4429.e19
33.678Citations (PDF)
71Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
Cell, 2021, 184, 4430-4446.e22
33.650Citations (PDF)
72A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Immunity, 2021, 54, 2399-2416.e6
22.698Citations (PDF)
73A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants
Immunity, 2021, 54, 2159-2166.e6
22.670Citations (PDF)
74Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
Nature Microbiology, 2021, 6, 1233-1244
16.0310Citations (PDF)
75Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118,
7.530Citations (PDF)
76Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118,
7.565Citations (PDF)
77Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
Journal of Molecular Biology, 2021, 433, 167177
4.141Citations (PDF)
78Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain
Journal of Virology, 2021, 95,
3.629Citations (PDF)
79Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
Lancet Microbe, The, 2021, 2, e527-e535
12.3109Citations (PDF)
80Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
JCI Insight, 2021, 6,
5.481Citations (PDF)
81Helminth–virus interactions: determinants of coinfection outcomes
Gut Microbes, 2021, 13,
10.240Citations (PDF)
82Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
MBio, 2021, 12,
4.426Citations (PDF)
83Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor
Nature, 2021, 598, 672-676
37.955Citations (PDF)
84Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity
Cell Host and Microbe, 2021, 29, 1634-1648.e5
15.114Citations (PDF)
85Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD
Cell Reports, 2021, 37, 109881
6.324Citations (PDF)
86Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Med, 2021, 2, 1327-1341.e4
7.036Citations (PDF)
87SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Cell Reports, 2021, 37, 110143
6.3179Citations (PDF)
88A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Cell, 2020, 183, 169-184.e13
33.6601Citations (PDF)
89Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors
Journal of Virology, 2020, 94,
3.641Citations (PDF)
90Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
Nature Communications, 2020, 11,
13.755Citations (PDF)
91A molecular understanding of alphavirus entry
PLoS Pathogens, 2020, 16, e1008876
4.4116Citations (PDF)
92An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses
Cell Reports Medicine, 2020, 1, 100035
6.69Citations (PDF)
93Dengue mouse models for evaluating pathogenesis and countermeasures
Current Opinion in Virology, 2020, 43, 50-58
5.049Citations (PDF)
94Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses
Immunity, 2020, 53, 1078-1094.e7
22.6132Citations (PDF)
95Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Nature Immunology, 2020, 21, 1506-1516
23.5767Citations (PDF)
96The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis
Cell, 2020, 182, 901-918.e18
33.6188Citations (PDF)
97LDLRAD3 is a receptor for Venezuelan equine encephalitis virus
Nature, 2020, 588, 308-314
37.9154Citations (PDF)
98Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
Cell Host and Microbe, 2020, 28, 465-474.e4
15.1190Citations (PDF)
99Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
Molecular Therapy - Methods and Clinical Development, 2020, 18, 402-414
4.1118Citations (PDF)
100Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
Nature Biomedical Engineering, 2020, 4, 1030-1043
22.461Citations (PDF)
101Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
Proceedings of the National Academy of Sciences of the United States of America, 2020, 117, 20803-20813
7.5196Citations (PDF)
102Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site
Cell Host and Microbe, 2020, 28, 699-711.e7
15.168Citations (PDF)
103Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature, 2020, 584, 443-449
37.91,110Citations (PDF)
104Structural basis of Chikungunya virus inhibition by monoclonal antibodies
Proceedings of the National Academy of Sciences of the United States of America, 2020, 117, 27637-27645
7.569Citations (PDF)
105Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge
Journal of Experimental Medicine, 2020, 217,
9.333Citations (PDF)
106Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
Science, 2020, 370, 950-957
36.3573Citations (PDF)
107Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs
Nature Microbiology, 2020, 5, 1490-1503
16.088Citations (PDF)
108Development and Validation of a Rapid Lateral Flow E1/E2-Antigen Test and ELISA in Patients Infected with Emerging Asian Strain of Chikungunya Virus in the Americas
Viruses, 2020, 12, 971
3.220Citations (PDF)
109Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Clinical Chemistry, 2020, 66, 1538-1547
1.1119Citations (PDF)
110De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Science, 2020, 370, 426-431
36.3686Citations (PDF)
111A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice
PLoS Pathogens, 2020, 16, e1008743
4.423Citations (PDF)
112Limited Regional Aerosol and Cloud Microphysical Changes Despite Unprecedented Decline in Nitrogen Oxide Pollution During the February 2020 COVID‐19 Shutdown in China
Geophysical Research Letters, 2020, 47,
4.152Citations (PDF)
113SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
Nature Immunology, 2020, 21, 1327-1335
23.5953Citations (PDF)
114Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection
Cell, 2020, 183, 1884-1900.e23
33.643Citations (PDF)
115Barrier-to-Autointegration Factor 1 Protects against a Basal cGAS-STING Response
MBio, 2020, 11,
4.442Citations (PDF)
116The continued threat of emerging flaviviruses
Nature Microbiology, 2020, 5, 796-812
16.01,023Citations (PDF)
117Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease
PLoS Pathogens, 2020, 16, e1008517
4.425Citations (PDF)
118Ultra-clean and smoky marine boundary layers frequently occur in the same season over the southeast Atlantic
Atmospheric Chemistry and Physics, 2020, 20, 2341-2351
4.614Citations (PDF)
119TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Science Immunology, 2020, 5,
13.4956Citations (PDF)
120Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies
Cell Host and Microbe, 2020, 27, 710-724.e7
15.145Citations (PDF)
121Substantial Cloud Brightening From Shipping in Subtropical Low Clouds
AGU Advances, 2020, 1,
5.4104Citations (PDF)
122Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Nature, 2020, 583, 290-295
37.92,037Citations (PDF)
123Growth, detection, quantification, and inactivation of SARS-CoV-2
Virology, 2020, 548, 39-48
2.3266Citations (PDF)
124A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Cell, 2020, 182, 744-753.e4
33.6541Citations (PDF)
125Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
Cell Host and Microbe, 2020, 28, 475-485.e5
15.1462Citations (PDF)
126Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Nature Medicine, 2020, 26, 1422-1427
33.0514Citations (PDF)
127An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis
Cell Host and Microbe, 2020, 27, 428-440.e9
15.145Citations (PDF)
128Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Cell Stem Cell, 2020, 26, 187-204.e10
16.4185Citations (PDF)
129Immune correlates of tuberculosis disease and risk translate across species
Science Translational Medicine, 2020, 12,
12.593Citations (PDF)
130MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2
PLoS Pathogens, 2020, 16, e1008292
4.439Citations (PDF)
131Chikungunya Virus Evades Antiviral CD8+T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues
Journal of Virology, 2020, 94,
3.646Citations (PDF)
132Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury
Proceedings of the National Academy of Sciences of the United States of America, 2020, 117, 32648-32656
7.545Citations (PDF)
133IMMU-43. ZIKA VIRUS TO TREAT GLIOMA: TURNING COLD TUMORS HOT
Neuro-Oncology, 2020, 22, ii114-ii114
1.00Citations (PDF)
134Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity
Journal of Experimental Medicine, 2019, 216, 2282-2301
9.375Citations (PDF)
135Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity
Cell Host and Microbe, 2019, 26, 493-503.e6
15.1131Citations (PDF)
136Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
Journal of Infectious Diseases, 2019, 220, 1577-1588
3.749Citations (PDF)
137Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation
Journal of Virology, 2019, 94,
3.671Citations (PDF)
138Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins
PLoS Pathogens, 2019, 15, e1008061
4.468Citations (PDF)
139Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody
Journal of Virology, 2019, 93,
3.612Citations (PDF)
140Dermal and muscle fibroblasts and skeletal myofibers survive chikungunya virus infection and harbor persistent RNA
PLoS Pathogens, 2019, 15, e1007993
4.477Citations (PDF)
141A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
Cell Reports, 2019, 28, 2634-2646.e4
6.324Citations (PDF)
142Mechanisms of Pathogen Invasion into the Central Nervous System
Neuron, 2019, 103, 771-783
11.0121Citations (PDF)
143A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
Nature Immunology, 2019, 20, 1291-1298
23.599Citations (PDF)
144Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and Drosophila
Cell Reports, 2019, 28, 2647-2658.e5
6.383Citations (PDF)
145Interferon lambda protects the female reproductive tract against Zika virus infection
Nature Communications, 2019, 10,
13.7109Citations (PDF)
146Therapeutic efficacy of favipiravir against Bourbon virus in mice
PLoS Pathogens, 2019, 15, e1007790
4.448Citations (PDF)
147Zika Virus Causes Acute Infection and Inflammation in the Ovary of Mice Without Apparent Defects in Fertility
Journal of Infectious Diseases, 2019, 220, 1904-1914
3.716Citations (PDF)
148Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor
Cell, 2019, 177, 1725-1737.e16
33.6182Citations (PDF)
149A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Science Immunology, 2019, 4,
13.4197Citations (PDF)
150Shared and Distinct Functions of Type I and Type III Interferons
Immunity, 2019, 50, 907-923
22.61,100Citations (PDF)
151Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
Science Immunology, 2019, 4,
13.480Citations (PDF)
152Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
Cell Reports, 2019, 26, 1585-1597.e4
6.320Citations (PDF)
153Immune responses at the maternal-fetal interface
Science Immunology, 2019, 4,
13.4602Citations (PDF)
154Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
Proceedings of the National Academy of Sciences of the United States of America, 2019, 116, 1591-1596
7.558Citations (PDF)
155Zika Virus Vaccine Development: Progress in the Face of New Challenges
Annual Review of Medicine, 2019, 70, 121-135
18.783Citations (PDF)
156Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability
Immunity, 2018, 48, 487-499.e5
22.6132Citations (PDF)
157Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus
MBio, 2018, 9,
4.442Citations (PDF)
158Zika virus–related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice
Science Translational Medicine, 2018, 10,
12.598Citations (PDF)
159Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice
Journal of Virology, 2018, 92,
3.661Citations (PDF)
160Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections
Cell Reports, 2018, 22, 3440-3453.e6
6.3120Citations (PDF)
161Time-dependent entrainment of smoke presents an observational challenge for assessing aerosol–cloud interactions over the southeast Atlantic Ocean
Atmospheric Chemistry and Physics, 2018, 18, 14623-14636
4.658Citations (PDF)
162Remote Sensing of Droplet Number Concentration in Warm Clouds: A Review of the Current State of Knowledge and Perspectives
Reviews of Geophysics, 2018, 56, 409-453
34.2310Citations (PDF)
163Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice
Cell Host and Microbe, 2018, 24, 743-750.e5
15.188Citations (PDF)
164Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Scientific Reports, 2018, 8,
3.440Citations (PDF)
165Cryo-EM Structures of Eastern Equine Encephalitis Virus Reveal Mechanisms of Virus Disassembly and Antibody Neutralization
Cell Reports, 2018, 25, 3136-3147.e5
6.365Citations (PDF)
166An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections
Cell Reports, 2018, 25, 3382-3392.e3
6.3116Citations (PDF)
167The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins
MSphere, 2018, 3,
3.072Citations (PDF)
168Intestinal Dysmotility Syndromes following Systemic Infection by Flaviviruses
Cell, 2018, 175, 1198-1212.e12
33.675Citations (PDF)
169Animal Models of Zika Virus Infection during Pregnancy
Viruses, 2018, 10, 598
3.270Citations (PDF)
170The emergence of Zika virus and its new clinical syndromes
Nature, 2018, 560, 573-581
37.9386Citations (PDF)
171Mxra8 is a receptor for multiple arthritogenic alphaviruses
Nature, 2018, 557, 570-574
37.9404Citations (PDF)
172Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy
Nature Communications, 2018, 9,
13.7106Citations (PDF)
173Zika virus vaccines: immune response, current status, and future challenges
Current Opinion in Immunology, 2018, 53, 130-136
5.255Citations (PDF)
174An Immunocompetent Mouse Model of Zika Virus Infection
Cell Host and Microbe, 2018, 23, 672-685.e6
15.1236Citations (PDF)
175Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement
Science Immunology, 2018, 3,
13.496Citations (PDF)
176A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions
Nature Microbiology, 2018, 4, 71-77
16.033Citations (PDF)
177Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein
Nature Microbiology, 2018, 4, 187-197
16.054Citations (PDF)
178MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-omics profiling
Analyst, The, 2017, 142, 442-448
3.161Citations (PDF)
179Mapping and Role of the CD8 + T Cell Response During Primary Zika Virus Infection in Mice
Cell Host and Microbe, 2017, 21, 35-46
15.1238Citations (PDF)
180Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis
Science Translational Medicine, 2017, 9,
12.579Citations (PDF)
181Animal Models of Zika Virus Infection, Pathogenesis, and Immunity
Journal of Virology, 2017, 91,
3.6254Citations (PDF)
182Modified mRNA Vaccines Protect against Zika Virus Infection
Cell, 2017, 168, 1114-1125.e10
33.6790Citations (PDF)
183Zika Virus Pathogenesis and Tissue Tropism
Cell Host and Microbe, 2017, 21, 134-142
15.1407Citations (PDF)
184AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses
Proceedings of the National Academy of Sciences of the United States of America, 2017, 114, 2024-2029
7.5201Citations (PDF)
185Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection
Journal of Interferon and Cytokine Research, 2017, 37, 287-294
1.753Citations (PDF)
186Vaccination strategies against Zika virus
Current Opinion in Virology, 2017, 23, 59-67
5.064Citations (PDF)
187TAM Receptors Are Not Required for Zika Virus Infection in Mice
Cell Reports, 2017, 19, 558-568
6.3148Citations (PDF)
188Negative regulators of the RIG‐I‐like receptor signaling pathway
European Journal of Immunology, 2017, 47, 615-628
3.1112Citations (PDF)
189A human antibody against Zika virus crosslinks the E protein to prevent infection
Nature Communications, 2017, 8,
13.7143Citations (PDF)
190Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine
Vaccine, 2017, 35, 283-292
3.121Citations (PDF)
191Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection
Nature Immunology, 2017, 18, 1261-1269
23.5121Citations (PDF)
192Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero
Cell Host and Microbe, 2017, 22, 366-376.e3
15.1161Citations (PDF)
193A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage
Nature Communications, 2017, 8,
13.7141Citations (PDF)
194Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice
Journal of Experimental Medicine, 2017, 214, 2303-2313
9.3202Citations (PDF)
195Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease
Cell, 2017, 170, 273-283.e12
33.6256Citations (PDF)
196Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge
Nature Communications, 2017, 8,
13.7144Citations (PDF)
197An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses
Cell Reports, 2017, 21, 1600-1612
6.371Citations (PDF)
198The FDA-approved drug sofosbuvir inhibits Zika virus infection
Antiviral Research, 2017, 137, 134-140
3.8236Citations (PDF)
199Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
PLoS Pathogens, 2017, 13, e1006635
4.4102Citations (PDF)
200A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis
PLoS Pathogens, 2017, 13, e1006178
4.489Citations (PDF)
201Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques
PLoS Neglected Tropical Diseases, 2017, 11, e0005637
3.065Citations (PDF)
202Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice
PLoS ONE, 2017, 12, e0177142
2.325Citations (PDF)
203Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization
PLoS Pathogens, 2017, 13, e1006743
4.421Citations (PDF)
204The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis
Journal of Virology, 2016, 90, 8212-8225
3.698Citations (PDF)
205Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
Cell Metabolism, 2016, 24, 158-166
25.21,430Citations (PDF)
206A Mouse Model of Zika Virus Pathogenesis
Cell Host and Microbe, 2016, 19, 720-730
15.1907Citations (PDF)
207MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis
Journal of Virology, 2016, 90, 7098-7108
3.628Citations (PDF)
208Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika Virus
Journal of Molecular Biology, 2016, 428, 3429-3448
4.136Citations (PDF)
209Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise
Cell, 2016, 165, 1081-1091
33.6808Citations (PDF)
210Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears
Cell Reports, 2016, 16, 3208-3218
6.3264Citations (PDF)
211A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I
Journal of Virology, 2016, 90, 10499-10512
3.627Citations (PDF)
212Structural Basis of Zika Virus-Specific Antibody Protection
Cell, 2016, 166, 1016-1027
33.6370Citations (PDF)
213Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence
Cell Reports, 2016, 16, 1326-1338
6.385Citations (PDF)
214The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses
Journal of Virology, 2016, 90, 8780-8794
3.698Citations (PDF)
215Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate
Nature Medicine, 2016, 22, 1256-1259
33.0264Citations (PDF)
216Enhancing dengue virus maturation using a stable furin over-expressing cell line
Virology, 2016, 497, 33-40
2.388Citations (PDF)
217Modeling Zika Virus Infection in Pregnancy
New England Journal of Medicine, 2016, 375, 481-484
34.597Citations (PDF)
218An ultrasensitive electrogenerated chemiluminescence-based immunoassay for specific detection of Zika virus
Scientific Reports, 2016, 6,
3.446Citations (PDF)
219Immune-Mediated Protection and Pathogenesis of Chikungunya Virus
Journal of Immunology, 2016, 197, 4210-4218
0.678Citations (PDF)
220Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
Nature, 2016, 540, 443-447
37.9407Citations (PDF)
221Innate immune escape by Dengue and West Nile viruses
Current Opinion in Virology, 2016, 20, 119-128
5.077Citations (PDF)
222Zika virus infection damages the testes in mice
Nature, 2016, 540, 438-442
37.9487Citations (PDF)
223Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses
Nature Immunology, 2016, 17, 966-975
23.5174Citations (PDF)
224Plasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis
MBio, 2016, 7,
4.475Citations (PDF)
225Mechanisms of Zika Virus Infection and Neuropathogenesis
DNA and Cell Biology, 2016, 35, 367-372
2.150Citations (PDF)
226Mechanisms of restriction of viral neuroinvasion at the blood–brain barrier
Current Opinion in Immunology, 2016, 38, 18-23
5.2108Citations (PDF)
227Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus
Journal of Virology, 2016, 90, 3112-3122
3.663Citations (PDF)
228Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
Journal of Virology, 2016, 90, 4864-4875
3.6438Citations (PDF)
229The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner
Journal of Virology, 2016, 90, 2600-2615
3.672Citations (PDF)
230Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System
Journal of Virology, 2016, 90, 189-205
3.643Citations (PDF)
231Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species
PLOS Currents, 2016, ,
1.668Citations (PDF)
232Occurrence and trends of eastern and central Pacific El Niño in different reconstructed SST data sets
Geophysical Research Letters, 2015, 42,
4.19Citations (PDF)
233Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection
PLoS ONE, 2015, 10, e0128636
2.359Citations (PDF)
234Age-Dependent Cell Trafficking Defects in Draining Lymph Nodes Impair Adaptive Immunity and Control of West Nile Virus Infection
PLoS Pathogens, 2015, 11, e1005027
4.4102Citations (PDF)
235Preparing for the Next Epidemic with Basic Virology
PLoS Pathogens, 2015, 11, e1005182
4.42Citations (PDF)
236Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis
Cell Reports, 2015, 13, 2553-2564
6.3107Citations (PDF)
237New insights into innate immune restriction of West Nile virus infection
Current Opinion in Virology, 2015, 11, 1-6
5.049Citations (PDF)
238Brief Report: Chikungunya Viral Arthritis in the United States: A Mimic of Seronegative Rheumatoid Arthritis
Arthritis and Rheumatology, 2015, 67, 1214-1220
6.1159Citations (PDF)
239The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional
Virus Research, 2015, 206, 99-107
2.696Citations (PDF)
240Oropouche Virus Infection and Pathogenesis Are Restricted by MAVS, IRF-3, IRF-7, and Type I Interferon Signaling Pathways in Nonmyeloid Cells
Journal of Virology, 2015, 89, 4720-4737
3.670Citations (PDF)
241Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control
Cell, 2015, 162, 488-492
33.6283Citations (PDF)
242Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus
Cell Host and Microbe, 2015, 18, 86-95
15.1134Citations (PDF)
243Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families
Journal of Virology, 2015, 89, 9465-9476
3.652Citations (PDF)
244Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Immunity, 2015, 43, 15-28
22.6478Citations (PDF)
245Innate immune interactions within the central nervous system modulate pathogenesis of viral infections
Current Opinion in Immunology, 2015, 36, 47-53
5.242Citations (PDF)
246IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon
PLoS Pathogens, 2015, 11, e1004863
4.4111Citations (PDF)
247Hepatitis C Virus RNA Replication Depends on Specific Cis- and Trans-Acting Activities of Viral Nonstructural Proteins
PLoS Pathogens, 2015, 11, e1004817
4.430Citations (PDF)
248Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier
Science Translational Medicine, 2015, 7,
12.5231Citations (PDF)
249Innate immune restriction and antagonism of viral RNA lacking 2׳-O methylation
Virology, 2015, 479-480, 66-74
2.3185Citations (PDF)
250RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression
Journal of Virology, 2015, 89, 12014-12025
3.643Citations (PDF)
251Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112, 13898-13903
7.558Citations (PDF)
252The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
Nature Medicine, 2015, 21, 1464-1472
33.0145Citations (PDF)
253Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
Cell, 2015, 163, 1095-1107
33.6212Citations (PDF)
254Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection
MBio, 2015, 6,
4.447Citations (PDF)
255Structure of Acidic pH Dengue Virus Showing the Fusogenic Glycoprotein Trimers
Journal of Virology, 2015, 89, 743-750
3.665Citations (PDF)
256Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection
PLoS Neglected Tropical Diseases, 2015, 9, e0004119
3.055Citations (PDF)
257GPR18 Controls Reconstitution of Mouse Small Intestine Intraepithelial Lymphocytes following Bone Marrow Transplantation
PLoS ONE, 2015, 10, e0133854
2.326Citations (PDF)
258Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge
PLoS ONE, 2014, 9, e87837
2.335Citations (PDF)
259Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus
PLoS ONE, 2014, 9, e93541
2.358Citations (PDF)
260c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells
Nature Immunology, 2014, 15, 884-893
23.596Citations (PDF)
261Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
PLoS Pathogens, 2014, 10, e1004072
4.459Citations (PDF)
262Genome-Wide RNAi Screen Identifies Broadly-Acting Host Factors That Inhibit Arbovirus Infection
PLoS Pathogens, 2014, 10, e1003914
4.487Citations (PDF)
263Experimental Infection of Rhesus Macaques and Common Marmosets with a European Strain of West Nile Virus
PLoS Neglected Tropical Diseases, 2014, 8, e2797
3.025Citations (PDF)
264Deficient IFN Signaling by Myeloid Cells Leads to MAVS-Dependent Virus-Induced Sepsis
PLoS Pathogens, 2014, 10, e1004086
4.473Citations (PDF)
265Interferon Regulatory Factor 5-Dependent Immune Responses in the Draining Lymph Node Protect against West Nile Virus Infection
Journal of Virology, 2014, 88, 11007-11021
3.628Citations (PDF)
266Dendritic Cells in Dengue Virus Infection: Targets of Virus Replication and Mediators of Immunity
Frontiers in Immunology, 2014, 5,
4.9130Citations (PDF)
267Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice
Vaccine, 2014, 32, 800-808
3.129Citations (PDF)
268K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5
Nature Immunology, 2014, 15, 231-238
23.5130Citations (PDF)
269Chikungunya Viruses That Escape Monoclonal Antibody Therapy Are Clinically Attenuated, Stable, and Not Purified in Mosquitoes
Journal of Virology, 2014, 88, 8213-8226
3.678Citations (PDF)
270Vaccine Development as a Means to Control Dengue Virus Pathogenesis: Do We Know Enough?
Annual Review of Virology, 2014, 1, 375-398
7.516Citations (PDF)
271IFIT1: A dual sensor and effector molecule that detects non-2′-O methylated viral RNA and inhibits its translation
Cytokine and Growth Factor Reviews, 2014, 25, 543-550
10.5117Citations (PDF)
272Increased Frequency of Tim-3 Expressing T Cells Is Associated with Symptomatic West Nile Virus Infection
PLoS ONE, 2014, 9, e92134
2.319Citations (PDF)
273Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus
PLoS ONE, 2014, 9, e112568
2.314Citations (PDF)
274Propagation, Quantification, Detection, and Storage of West Nile Virus
Current Protocols in Microbiology, 2013, 31,
0.0119Citations (PDF)
275Non-structural protein-1 is required for West Nile virus replication complex formation and viral RNA synthesis
Virology Journal, 2013, 10,
3.649Citations (PDF)
276A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice
Journal of Virology, 2013, 87, 1926-1936
3.669Citations (PDF)
277Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus
PLoS Pathogens, 2013, 9, e1003312
4.4264Citations (PDF)
278Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
Nature, 2013, 505, 691-695
37.9896Citations (PDF)
279Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
PLoS Pathogens, 2012, 8, e1002930
4.4116Citations (PDF)
280A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein
Journal of General Virology, 2012, 93, 20-26
3.322Citations (PDF)
281Cell-intrinsic innate immune control of West Nile virus infection
Trends in Immunology, 2012, 33, 522-530
10.452Citations (PDF)
282The broad-spectrum antiviral functions of IFIT and IFITM proteins
Nature Reviews Immunology, 2012, 13, 46-57
53.8844Citations (PDF)
283Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein ProtectIn Vivovia Fcγ Receptor and Complement-Dependent Effector Mechanisms
Journal of Virology, 2011, 85, 11567-11580
3.6123Citations (PDF)
284Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
Journal of Virology, 2011, 85, 7005-7019
3.6123Citations (PDF)
2852′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Nature, 2010, 468, 452-456
37.9865Citations (PDF)
286The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
PLoS Pathogens, 2010, 6, e1000823
4.4196Citations (PDF)
287Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus
Journal of Infectious Diseases, 2009, 200, 202-205
3.737Citations (PDF)
288Virus and Host Determinants of West Nile Virus Pathogenesis
PLoS Pathogens, 2009, 5, e1000452
4.441Citations (PDF)
289A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
PLoS Pathogens, 2009, 5, e1000453
4.491Citations (PDF)
290Progress on the development of therapeutics against West Nile virus
Antiviral Research, 2009, 83, 214-227
3.8111Citations (PDF)
291Mechanisms of Evasion of the Type I Interferon Antiviral Response by Flaviviruses
Journal of Interferon and Cytokine Research, 2009, 29, 521-530
1.775Citations (PDF)
292The host immunologic response to West Nile encephalitis virus
Frontiers in Bioscience - Landmark, 2009, Volume, 3024
5.856Citations (PDF)
293The structural immunology of antibody protection against West Nile virus
Immunological Reviews, 2008, 225, 212-225
6.4126Citations (PDF)
294Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
PLoS Pathogens, 2008, 4, e1000060
4.4165Citations (PDF)
295Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus
Journal of Virology, 2007, 81, 11828-11839
3.6162Citations (PDF)
296The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Cell Host and Microbe, 2007, 1, 135-145
15.1292Citations (PDF)
297Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein
Journal of Virology, 2006, 80, 12149-12159
3.6293Citations (PDF)
298A genetic basis for human susceptibility to West Nile virus
Trends in Microbiology, 2006, 14, 287-289
8.133Citations (PDF)
299A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection
Virology, 2006, 346, 53-65
2.3227Citations (PDF)
300Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Nature Medicine, 2005, 11, 522-530
33.0500Citations (PDF)
301Structural basis of West Nile virus neutralization by a therapeutic antibody
Nature, 2005, 437, 764-769
37.9343Citations (PDF)
302Development of effective therapies against West Nile virus infection
Expert Review of Anti-Infective Therapy, 2005, 3, 931-944
3.824Citations (PDF)
303Evasion of innate and adaptive immunity by flaviviruses
Immunology and Cell Biology, 2003, 81, 196-206
2.6110Citations (PDF)
304Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus
Viral Immunology, 2003, 16, 259-278
1.1188Citations (PDF)
305A Critical Role for Induced IgM in the Protection against West Nile Virus Infection
Journal of Experimental Medicine, 2003, 198, 1853-1862
9.3289Citations (PDF)
306AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
ELife, 0, 5,
0.778Citations (PDF)